Related Experiment Video
Updated: Jan 29, 2026

Echocardiographic Approaches and Protocols for Comprehensive Phenotypic Characterization of Valvular Heart Disease in Mice
Published on: February 14, 2017
Hypertension and Valvular Heart Disease: An Overview of a Complex and Clinically Meaningful Relationship
Roxana Oana Darabont1,2, Diana Mihalcea1,2, Dragos Vinereanu1,2
1Cardiology and Cardiovascular Surgery Department, "Carol Davila" University of Medicine and Pharmacy, 020021 Bucharest, Romania.
Insights
Hypertension (HTN) significantly impacts valvular heart disease (VHD) by stressing valves and altering blood flow. Managing blood pressure is crucial for VHD patients, though specific targets for mitral regurgitation require further research.
Area of Science:
- Cardiology
- Hypertension Research
- Valvular Heart Disease Studies
Background:
- The link between hypertension (HTN) and valvular heart disease (VHD) is increasingly recognized.
- Approximately 45% of VHD patients also have HTN, with this association strengthening with age.
- HTN exacerbates VHD through mechanical valve stress and altered hemodynamics.
Purpose of the Study:
- To review the impact of HTN on VHD development and progression.
- To examine HTN's effect on VHD patient prognosis.
- To discuss current data on blood pressure management in VHD.
Main Methods:
- Literature review of studies on hypertension and valvular heart disease.
- Analysis of epidemiological data linking blood pressure to VHD risk.
- Synthesis of current guidelines and research on blood pressure management strategies.
Main Results:
- Elevated blood pressure significantly increases the risk of aortic valvular disease and mitral regurgitation.
- A 20 mmHg increase in systolic blood pressure triples the risk of these valvular conditions.
- HTN contributes to VHD onset and progression via mechanical stress and hemodynamic changes.
Conclusions:
- Hypertension is a key factor in the development and worsening of valvular heart disease.
- Further research is needed to establish optimal blood pressure targets and drug therapies for mitral regurgitation.
- Understanding the HTN-VHD relationship is critical for improving patient outcomes.
Abstract:
The overlooked relationship between hypertension (HTN) and valvular heart disease (VHD) has been brought to wider attention by large-scale population studies and the latest guidelines. Approximately 45% of patients with VHD have been diagnosed with HTN. This association increases with age, but cannot be explained solely by the rising prevalence of both conditions. HTN promotes the onset or worsening of VHD by mechanically stressing the valves and by modified blood flow dynamics through increased filling pressures and afterload. It has been shown that a 20 mmHg rise in BP triples the risk of aortic valvular disease and mitral regurgitation. This review will address the impact of HTN on the occurrence and progression of valvular lesions, its effect on the prognosis of patients with VHD, and the available data on blood pressure management. As long as relatively well-documented data on aortic valve disease are available, studies are still needed to clarify target blood pressure values under therapy and the most appropriate drug classes for mitral regurgitation, especially in its primary forms.
More Related Videos
07:41A Model of Reverse Vascular Remodeling in Pulmonary Hypertension Due to Left Heart Disease by Aortic Debanding in Rats
Published on: March 1, 2022
07:41Induction and Phenotyping of Acute Right Heart Failure in a Large Animal Model of Chronic Thromboembolic Pulmonary Hypertension
Published on: March 17, 2022
Related Concept Videos
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Overview of the Heart
The heart's structure...
Dose-Response Relationship: Overview
Clinical Trials: Overview
Complexation Equilibria: Overview
The equilibrium constant of the complexation reaction is represented as the formation constant...